Notably, in addition to the knockdowns of oncogenic KRAS, overexpression of mutant KRAS oncogenes also strongly induced the upregulation of these AATs, AA uptake, mTOR activation (phospho‐S6), and cell proliferation in KRAS wt CRC cells (Fig. 3A–E). This evidence concerns the gene KRAS and colorectal carcinoma.